Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec 14:9:257.
doi: 10.1186/s13014-014-0257-8.

Refractory trigeminal neuralgia treatment outcomes following CyberKnife radiosurgery

Sana D Karam  1 , Alexander Tai  2 , James W Snider  3 , Shilpa Bhatia  4 , Edward J Bedrick  5 , Abdul Rashid  6 , Ann Jay  7 , Christopher Kalhorn  8 , Nathan Nair  9 , K William Harter  10 , Sean P Collins  11 , Walter Jean  12   13
Affiliations

Refractory trigeminal neuralgia treatment outcomes following CyberKnife radiosurgery

Sana D Karam et al. Radiat Oncol. .

Abstract

Introduction: A handful of studies have reported outcomes with CyberKnife radiosurgery (CKRS) for the treatment of trigeminal neuralgia. However, the follow-up has been short with no minimum follow-up required and have included patients with short duration of symptoms. Here we report our institutional experience on patients with a minimum follow-up of 1 year and a median follow-up of 28 months (mean 38.84 months).

Methods: Twenty-five patients with medically and surgically intractable TN received CKRS with a mean marginal radiation dose of 64 Gy applied to an average isodose line of 86% of the affected trigeminal nerve. Follow-up data were obtained by clinical examination and telephone questionnaire. Outcome results were categorized based on the Barrow Neurological Institute (BNI) pain scale with BNI I-III considered to be good outcomes and BNI IV-V considered as treatment failure. BNI facial numbness score was used to assess treatment complications.

Results: A large proportion of patients (42.9%) reported pain relief within 1 month following CKRS treatment. The mean time to recurrence of severe pain was 27.8 months (range 1-129 months). At median follow-up of 28 months (mean 38.84 months), actuarial rate of freedom from severe pain (BNI ≥ III) was 72%. At last follow-up 2 (8%) patients had freedom from any pain and no medications (BNI I) and the majority (48%) had some pain that was adequately controlled with medications. Seven patients (28%) had no response to treatment and continued to suffer from severe pain (BNI IV or V). Patient's diabetic status and overall post-treatment BNI facial numbness scores were statistically significant predictors of treatment outcomes.

Conclusion: CKRS represents an acceptable salvage option for with medically and/or surgically refractory patients. Even patients with severely debilitating symptoms may experience significant and sustained pain relief after CKRS. Particularly, CKRS remains an attractive option in patients who are not good surgical candidates or possibly even failed surgical therapy. This data should help in setting realistic expectations for weighing the various available treatment options.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Example of CyberKnife radiosurgery plan for trigemial neuralgia. A. Screen shot taken from the CyberKnife (Accuray, Inc., Sunnyvale, CA) treatment planning workstation depicting a representative radiosurgical plan for trigeminal neuralgia. Yellow and brown contours refer to the brainstem and temporal lobe, respectively. B. Higher magnification image illustrating the dose distribution within the target volume.
Figure 2
Figure 2
Kaplan-Meier curve for time from CyberKnife radiosurgery (CKRS) to Barrow Neurologic Institute (BNI) class IV to V pain relapse (i.e., freedom from severe pain).
Figure 3
Figure 3
Kaplan-Meier curve for time from CyberKnife radiosurgery (CKRS) to improvement in Barrow Neurologic Institute (BNI) numbness score.
See this image and copyright information in PMC

References

    1. Yen CP, Schlesinger D, Sheehan JP. Gamma Knife(R) radiosurgery for trigeminal neuralgia. Expert Rev Med Devices. 2011;8(6):709–721. doi: 10.1586/erd.11.46. - DOI - PubMed
    1. Katusic S, Beard CM, Bergstralh E, Kurland LT. Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945–1984. Ann Neurol. 1990;27(1):89–95. doi: 10.1002/ana.410270114. - DOI - PubMed
    1. Dieleman JP, Kerklaan J, Huygen FJ, Bouma PA, Sturkenboom MC. Incidence rates and treatment of neuropathic pain conditions in the general population. Pain. 2008;137(3):681–688. doi: 10.1016/j.pain.2008.03.002. - DOI - PubMed
    1. Burchiel KJ. A new classification for facial pain. Neurosurgery. 2003;53(5):1164–1166. doi: 10.1227/01.NEU.0000088806.11659.D8. - DOI - PubMed
    1. Adler JR, Jr, Bower R, Gupta G, Lim M, Efron A, Gibbs IC, Chang SD, Soltys SG. Nonisocentric radiosurgical rhizotomy for trigeminal neuralgia. Neurosurgery. 2009;64(2 Suppl):A84–A90. doi: 10.1227/01.NEU.0000341631.49154.62. - DOI - PubMed

Publication types